Product
ADVATE
Aliases
octocog alfa, rAHF-PFM
5 clinical trials
2 indications
Indication
Hemophilia AIndication
Von Willebrand DiseaseClinical trial
Phase 4, Multicenter, Prospective, Interventional, Post-Marketing Study in Hemophilia A Patients in India Receiving ADVATE as On-Demand or Prophylaxis Under Standard Clinical PracticeStatus: Completed, Estimated PCD: 2023-02-10
Clinical trial
ADVATE/ ADYNOVI Hemophilia A Outcome DatabaseStatus: Completed, Estimated PCD: 2024-01-16
Clinical trial
A Phase I, Multicentre, Open-label Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII, Fc Fusion Protein for Injection in Children With Severe Hemophilia AStatus: Completed, Estimated PCD: 2021-11-15
Clinical trial
An Open-Label, Multicenter Evaluation of the Pharmacokinetics,Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW117) in Patients With Severe Hemophilia A.Status: Completed, Estimated PCD: 2021-10-17
Clinical trial
A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With rVWF in Children Diagnosed With Severe Von Willebrand DiseaseStatus: Not yet recruiting, Estimated PCD: 2027-02-20